BriaCell Therapeutics's total assets for Q3 2025 were C$17.00M, an increase of 81.57% from the previous quarter. BCTX total liabilities were C$5.06M for the fiscal quarter, a -17.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.